The whole world of gambling is on your smartphone with the Mostbet app - join us!
Home  »  Hot Stocks   »  CEL-SCI Corporation (CVM) Stock: A Study of the Ma...

CEL-SCI Corporation (CVM) Stock: A Study of the Market Performance

The stock of CEL-SCI Corporation (CVM) has seen a 5.69% increase in the past week, with a 4.00% gain in the past month, and a -44.68% decrease in the past quarter. The volatility ratio for the week is 6.08%, and the volatility levels for the past 30 days are at 7.06% for CVM. The simple moving average for the past 20 days is -1.52% for CVM’s stock, with a -42.74% simple moving average for the past 200 days.

Is It Worth Investing in CEL-SCI Corporation (AMEX: CVM) Right Now?

compared to its average ratio and a 36-month beta value of 1.35. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

Do You Know The Best Place To Find Gains In Volatile Markets?

In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.

Click here for full details and to join for free

The average price point forecasted by analysts for CEL-SCI Corporation (CVM) is $10.00, which is $7.2 above the current market price. The public float for CVM is 45.55M, and currently, short sellers hold a 11.98% ratio of that float. The average trading volume of CVM on September 20, 2023 was 334.31K shares.

CVM) stock’s latest price update

CEL-SCI Corporation (AMEX: CVM) has seen a rise in its stock price by 8.33 in relation to its previous close of 1.20. However, the company has experienced a 5.69% gain in its stock price over the last five trading sessions. InvestorPlace reported 2023-07-18 that CEL-SCI (NYSEMKT: CVM ) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering. CEL-SCI is offering up 2.5 million shares of its common stock at a price of $2 per share.

Analysts’ Opinion of CVM

Many brokerage firms have already submitted their reports for CVM stocks, with H.C. Wainwright repeating the rating for CVM by listing it as a “Buy.” The predicted price for CVM in the upcoming period, according to H.C. Wainwright is $18 based on the research report published on January 13, 2020 of the previous year 2020.

CVM Trading at -18.27% from the 50-Day Moving Average

After a stumble in the market that brought CVM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -68.02% of loss for the given period.

Volatility was left at 7.06%, however, over the last 30 days, the volatility rate increased by 6.08%, as shares sank -7.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -46.28% lower at present.

During the last 5 trading sessions, CVM rose by +5.69%, which changed the moving average for the period of 200-days by -56.23% in comparison to the 20-day moving average, which settled at $1.3150. In addition, CEL-SCI Corporation saw -44.68% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for CVM

The total capital return value is set at -60.12, while invested capital returns managed to touch -62.45. Equity return is now at value -144.40, with -81.70 for asset returns.

Based on CEL-SCI Corporation (CVM), the company’s capital structure generated 47.58 points at debt to equity in total, while total debt to capital is 32.24. Total debt to assets is 30.29, with long-term debt to equity ratio resting at 42.20. Finally, the long-term debt to capital ratio is 28.59.

The liquidity ratio also appears to be rather interesting for investors as it stands at 5.45.


To put it simply, CEL-SCI Corporation (CVM) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.